Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: A nationwide cohort study

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 10, 2012, Pages 766-775

  Thorsteinsson, Kristina ^a   Ladelund, Steen ^b   Jensen Fangel, Soren ^c   Larsen, Mette Vang ^a   Johansen, Isik Somuncu ^d   Katzenstein, Terese L ^e   Pedersen, Gitte ^f   Storgaard, Merete ^c   Obel, Niels ^e   Lebech, Anne Mette ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

AIDS defining illnesses; Gender differences; HIV; Mortality; Route of transmission

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HETEROSEXUAL FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LESBIAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POISSON DISTRIBUTION; POPULATION BASED CASE CONTROL STUDY; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 84866648402     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.684220     Document Type: Article

References (43)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic. UNAIDS; December 2010. Available at: http://www.unhcr.org/ refworld/docid/4cfca9c62.html (accessed 21 March 2012).
2. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007;146:87-95.
3. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio MA, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003;362:22-9.
4. Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One 2011; 6:e22698.
5. Leone S, Gregis G, Quinzan G, Velenti D, Cologni G, Soavi L, et al. Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort. Infection 2011;39:13-20.
6. Zwahlen M, Harris R, May M, Hogg R, Costagliola D, de Wolf F, et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol 2009;38:1624-33.
7. Jagger C, Weston C, Cambois E, van Oyen H, Nusselder W, Doblhammer G, et al. Inequalities in health expectancies at older ages in the European Union: fi ndings from the Survey of Health and Retirement in Europe (SHARE). J Epidemiol Community Health 2011;65:1030-5.
8. Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, et al. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. Am J Epidemiol 2008;168:532-40.
9. Kesselring AM, Gras L, Wit FW, Smit C, Geerlings SE, Mulder JW, et al. Immune restoration and onset of new AIDS-defi ning events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands. Antivir Ther 2010;15:871-9.
10. Junghans C, Low N, Chan P, Witschi A, Vernazza P, Egger M. Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS 1999;13:2547-54.
11. Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis 2009;199:991-8.
12. Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, et al. Sex, race, and geographic region infl uence clinical outcomes following primary HIV-1 infection. J Infect Dis 2011;203:442-51.
13. Woldemichael G, Christiansen D, Thomas S, Benbow N. Demographic characteristics and survival with AIDS: health disparities in Chicago, 1993-2001. Am J Public Health 2009; 99(Suppl 1):S118-23.
14. Moore AL, Sabin CA, Johnson MA, Phillips AN. Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort study. J Acquir Immune Defi c Syndr 2002;29:197-202.
15. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001;344:720-5.
16. Finkel DG, John G, Holland B, Slim J, Smith SM. Women have a greater immunological response to effective virological HIV-1 therapy. AIDS 2003;17:2009-11.
17. Floridia M, Giuliano M, Palmisano L, Vella S. Gender differences in the treatment of HIV infection. Pharmacol Res 2008;58:173-82.
18. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 2000; 355:1131-7.
19. Ndiaye B, Salleron J, Vincent A, Bataille P, Bonnevie F, Choisy P, et al. Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007. BMC Infect Dis 2011;11:11.
20. Helleberg M, Engsig FN, Kronborg G, Laursen AL, Pedersen G, Larsen O, et al. Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis 2012;44:282-8.
21. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort profile: the Danish HIV cohort study. Int J Epidemiol 2009;38:1202-6.
22. Statistics Denmark. Available at: http://www.statistikbanken. dk/statbank5a/default.asp?w = 1440 (accessed 1 April 2011).
23. From the Centers for Disease Control and Prevention. 1993 revised classifi cation system for HIV infection and expanded surveillance case defi nition for AIDS among adolescents and adults. JAMA 1993;269:460.
24. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16: 1141-54.
25. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
26. Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet 2010;376:340-5.
27. Rajasuriar R, Gouillou M, Spelman T, Read T, Hoy J, Law M, et al. Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database. PLoS One 2011;6:e20713.
28. Giordano TP, Bartsch G, Zhang Y, Tedaldi E, Absalon J, Mannheimer S, et al. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS 2010;24:287-95.
29. Achhra AC, Zhou J, Dabis F, Pujari S, Thiebaut R, Law MG, et al. Difference in absolute CD4 + count according to CD4 percentage between Asian and Caucasian HIV-infected patients. J AIDS Clin Res 2010;1:1-4.
30. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009;15:955-9.
31. Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, et al. Do gender differences in CD4 cell counts matter? AIDS 1999;13:2361-4.
32. Taarnhoj GA, Engsig FN, Ravn P, Johansen IS, Larsen CS, Roge B, et al. Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007. BMC Pulm Med 2011;11:26.
33. Hubert JB, Rouzioux C, Boufassa F, Delfraissy JF, Meyer L. Gender, disease progression and response to HAART. Abstract ThOrC1448. XIV International AIDS Conference, Barcelona, Spain, 7-12 July 2002.
34. Perez-Hoyos S, del Amo J, Muga R, del Romero J, Garcia de OP, Guerrero R, et al. Effectiveness of highly active antiret-roviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category. AIDS 2003;17:353-9.
35. Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M, et al. Factors associated with specifi c causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010;24:1537-48.
36. Petersen TS, Andersen SE, Gerstoft J, Thorsteinsson K, Larsen CS, Pedersen G, et al. Adherence to national guidelines for initiation of antiretroviral regimens in HIV patients: a Danish nationwide study. Br J Clin Pharmacol 2011;72:116-24.
37. Hessol NA, Kalinowski A, Benning L, Mullen J, Young M, Palella F, et al. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clin Infect Dis 2007;44:287-94.
38. Larsen MV, Omland LH, Gerstoft J, Larsen CS, Jensen J, Obel N, et al. Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study. Addiction 2010;105:529-35.
39. Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, et al. Impact of hepatitis C virus coin-fection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis 2006;42:1481-7.
40. Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology 2010;52: 1497-505.
41. Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio MA, et al. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS 2003;17:1179-93.
42. The Danish National Board of Health. Copenhagen: Sund-hedsstyrelsen. Available at: http://www.sst.dk/Sundhed%20 og%20forebyggelse/Tobak/Tal-og- undersoegelser/Danskernes-rygevaner/UdvilkingDec2010.aspx (accessed 21 March 2012).
43. Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). 2012. http://www.humanmortality.de.